Mylo, a platform for expecting and new mothers, has announced a funding round of $17 million led by W Health Ventures, a US-based digital health investor, ITC and Endiya Partners.
An Expert panel of India’s central drug authority has suggested granting emergency use authorisation for Biological E’s COVID-19 vaccine Corbevax for children in the five to 11 years age group with certain conditions, official sources...
Innovative credit products that include funds against Intellectual property rights are being examined by the government with an aim to increase the credit flow to the pharmaceuticals industry.
Even Healthcare, a health-tech firm and healthcare provider, under its 'Even Plus' and 'Even Lite' plans, offers its customers unlimited outpatient department (OPD) which includes doctor consultations and diagnostics...
Ramsay Health Care Ltd, Australia's largest private hospital operator, said on Wednesday it received a A$20.05 billion ($14.80 billion) indicative takeover offer from a consortium led by private equity giant KKR & Co...
The National Pharmaceutical Pricing Authority has initiated efforts to track the availability of essential drugs across the countryby creating a national level digital platform in which the stock positions could be updated by the stakeholders....
Health insurer Cigna Corp's Evernorth unit would partner with Kaiser Permanente to help patients enrolled in some its rival's health plans gain access to doctors while traveling.
Alembic Pharmaceuticals Limited today announced that it has received tentative approval from the US Food & Drug Administration for its Abbreviated New Drug Application (ANDA) for Ivabradine tablets, 5 mg and 7.5 mg.
Sanofi India Limited told that its Board of Directors has appointed Rodolfo Hrosz as the Company’s new Managing Director with effect from June 1, 2022, subject to regulatory approvals. He will transition from being Sanofi’s General Manager...
Phase 3 clinical trials of new breast cancer treatment approved in the U.S. and Europe will be conducted in Korea.